PIM
CRL icon

Perkins Investment Management’s Charles River Laboratories CRL Stock Holding History

Perkins Investment Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-5,791
Closed -$310K – 249
2014
Q2 		$310K Sell
5,791
-364,625
-98% -$20M ﹤0.01% 245
2014
Q1 		$22.4M Sell
370,416
-1,655,860
-82% -$96.5M 0.17% 133
2013
Q4 		$107M Sell
2,026,276
-854,537
-30% -$42.9M 0.74% 45
2013
Q3 		$133M Sell
2,880,813
-502,029
-15% -$23M 0.92% 37
2013
Q2 		$139M Buy
+3,382,842
New +$145M 0.94% 30

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
FC
Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Perkins Investment Management's CRL Position: Q3 2014 in Review

Perkins Investment Management sold out of Charles River Laboratories (CRL) in Q3 2014, closing a stake of 5,791 shares — an estimated $310K sold.

Perkins Investment Management first reported a position in CRL in Q2 2013 and held it in 5 quarters. The position peaked at $139M in Q2 2013. 255 funds tracked by Wall St. Rank hold CRL as of Q3 2014.

  • Perkins Investment Management reported no remaining Charles River Laboratories position as of Q3 2014 after selling out during the quarter.
  • Perkins Investment Management sold 5,791 Charles River Laboratories shares in Q3 2014, an estimated $310K.
  • Perkins Investment Management first reported a position in Charles River Laboratories in Q2 2013 and held it in 5 quarters.
  • Perkins Investment Management's Charles River Laboratories position peaked at $139M in Q2 2013.
  • 255 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2014.

Based on Perkins Investment Management's 13F filing for Q3 2014, filed 14 Nov 2014.